Pain Clinical Trial
Official title:
The Effects of the Parents' Voice to Reduce the Heel Puncture Pain in High-Risk Neonates
Verified date | February 2022 |
Source | National Yang Ming University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
High-risk neonates are forced to be separated from their parents due to hospitalization, and clinical medical treatment often causes pain and physical stress in high-risk newborns. Many literatures have confirmed that the mother's voice is positively helpful to the physiology of high-risk newborns, but few studies have been conducted on the father's voice. However, the parenting process is not only a link between the mother-child relationship, but also the impact of parental voice on high-risk newborns infants. Parent roles are expecting. The purpose of this study is to explore the effectiveness of parental voice intervention in high-risk newborns' heel puncture in reducing pain, and to further compare the mother and father's voice characteristics to the analysis of the pain degree of high-risk newborns.
Status | Completed |
Enrollment | 105 |
Est. completion date | February 23, 2022 |
Est. primary completion date | September 26, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 32 Weeks and older |
Eligibility | Inclusion Criteria: - High-risk newborns over 32 weeks of age. - Those who want to receive blood film collection for newborn screening on the third day of birth. - The incubator is used for care during the hospitalization. - The mother or father of the research subject can participate in the test all the way. - After explaining and reading the consent form, the parents of the research subjects agree to participate in the research and obtain written consent. Exclusion Criteria: - Apgar Score is still below 7 in the fifth minute. - Being treated with a high-frequency positive pressure respirator. - Suffering from congenital diseases including: ear canal malformation, cerebral palsy, Down's syndrome, congenital cyanotic heart disease. - After the doctor's assessment, the patient should continue fasting due to the condition or restrict breastfeeding on demand. - Instability of blood glucose after birth requires close monitoring of blood glucose, and has received more than three (including) heel puncture experiences. - Birth injuries of the body due to the birth process, such as broken fetal head and broken collarbone. - Are receiving medical treatment with sedatives. |
Country | Name | City | State |
---|---|---|---|
Taiwan | National Yang-Ming University | Taipei |
Lead Sponsor | Collaborator |
---|---|
National Yang Ming University |
Taiwan,
Alemdar DK, Özdemir FK. Effects of Covering the Eyes versus Playing Intrauterine Sounds on Premature Infants' Pain and Physiological Parameters during Venipuncture. J Pediatr Nurs. 2017 Nov - Dec;37:e30-e36. doi: 10.1016/j.pedn.2017.06.016. Epub 2017 Jul 24. — View Citation
Alemdar DK. Effect of recorded maternal voice, breast milk odor, and incubator cover on pain and comfort during peripheral cannulation in preterm infants. Appl Nurs Res. 2018 Apr;40:1-6. doi: 10.1016/j.apnr.2017.12.001. Epub 2017 Dec 14. — View Citation
Carvalho MES, Justo JMRM, Gratier M, Tomé T, Pereira E, Rodrigues H. Vocal responsiveness of preterm infants to maternal infant-directed speaking and singing during skin-to-skin contact (Kangaroo Care) in the NICU. Infant Behav Dev. 2019 Nov;57:101332. doi: 10.1016/j.infbeh.2019.101332. Epub 2019 Aug 14. — View Citation
Chirico G, Cabano R, Villa G, Bigogno A, Ardesi M, Dioni E. Randomised study showed that recorded maternal voices reduced pain in preterm infants undergoing heel lance procedures in a neonatal intensive care unit. Acta Paediatr. 2017 Oct;106(10):1564-1568. doi: 10.1111/apa.13944. Epub 2017 Jul 5. — View Citation
Flacking R, Breili C, Eriksson M. Facilities for presence and provision of support to parents and significant others in neonatal units. Acta Paediatr. 2019 Dec;108(12):2186-2191. doi: 10.1111/apa.14948. Epub 2019 Sep 2. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in heart rate from 3rd minute before the heel puncture to 10th minute after the heel puncture | Measure the heart rate at 3rd minute before the heel puncture, during, and at 1st, 5th and 10th minutes after the heel puncture | Measure the heart rate at 3rd minute before the heel puncture | |
Primary | Change in heart rate from 3rd minute before the heel puncture to 10th minute after the heel puncture | Measure the heart rate at 3rd minute before the heel puncture, during, and at 1st, 5th and 10th minutes after the heel puncture. | Measure the heart rate during the heel puncture | |
Primary | Change in heart rate from 3rd minute before the heel puncture to 10th minute after the heel puncture | Measure the heart rate at 3rd minute before the heel puncture, during, and at 1st, 5th and 10th minutes after the heel puncture | Measure the heart rate at 1st minute after the heel puncture | |
Primary | Change in heart rate from 3rd minute before the heel puncture to 10th minute after the heel puncture | Measure the heart rate at 3rd minute before the heel puncture, during, and at 1st, 5th and 10th minutes after the heel puncture | Measure the heart rate at 5th minute after the heel puncture | |
Primary | Change in heart rate from 3rd minute before the heel puncture to 10th minute after the heel puncture | Measure the heart rate at 3rd minute before the heel puncture, during, and at 1st, 5th and 10th minutes after the heel puncture | Measure the heart rate at 10th minute after the heel puncture | |
Primary | Change in respiratory rate from 3rd minute before the heel puncture to 10th minute after the heel puncture | Measure the respiratory rate at 3rd minute before the heel puncture, during, and at 1st, 5th and 10th minutes after the heel puncture | Measure the respiratory rate at 3rd minute before the heel puncture | |
Primary | Change in respiratory rate from 3rd minute before the heel puncture to 10th minute after the heel puncture | Measure the respiratory rate at 3rd minute before the heel puncture, during, and at 1st, 5th and 10th minutes after the heel puncture | Measure the respiratory rate during the heel puncture | |
Primary | Change in respiratory rate from 3rd minute before the heel puncture to 10th minute after the heel puncture | Measure the respiratory rate at 3rd minute before the heel puncture, during, and at 1st, 5th and 10th minutes after the heel puncture | Measure the respiratory rate at 1st minute after the heel puncture | |
Primary | Change in respiratory rate from 3rd minute before the heel puncture to 10th minute after the heel puncture | Measure the respiratory rate at 3rd minute before the heel puncture, during, and at 1st, 5th and 10th minutes after the heel puncture | Measure the respiratory rate at 5th minute after the heel puncture | |
Primary | Change in respiratory rate from 3rd minute before the heel puncture to 10th minute after the heel puncture | Measure the respiratory rate at 3rd minute before the heel puncture, during, and at 1st, 5th and 10th minutes after the heel puncture | Measure the respiratory rate at 10th minute after the heel puncture | |
Primary | Change in oxygen saturation from 3rd minute before the heel puncture to 10th minute after the heel puncture | Measure the oxygen saturation at 3rd minute before the heel puncture, during, and at 1st, 5th and 10th minutes after the heel puncture | Measure the oxygen saturation at 3rd minute before the heel puncture | |
Primary | Change in oxygen saturation from 3rd minute before the heel puncture to 10th minute after the heel puncture | Measure the oxygen saturation at 3rd minute before the heel puncture, during, and at 1st, 5th and 10th minutes after the heel puncture | Measure the oxygen saturation during the heel puncture | |
Primary | Change in oxygen saturation from 3rd minute before the heel puncture to 10th minute after the heel puncture | Measure the oxygen saturation at 3rd minute before the heel puncture, during, and at 1st, 5th and 10th minutes after the heel puncture | Measure the oxygen saturation at 1st minute after the heel puncture | |
Primary | Change in oxygen saturation from 3rd minute before the heel puncture to 10th minute after the heel puncture | Measure the oxygen saturation at 3rd minute before the heel puncture, during, and at 1st, 5th and 10th minutes after the heel puncture | Measure the oxygen saturation at 5th minute after the heel puncture | |
Primary | Change in oxygen saturation from 3rd minute before the heel puncture to 10th minute after the heel puncture | Measure the oxygen saturation at 3rd minute before the heel puncture, during, and at 1st, 5th and 10th minutes after the heel puncture | Measure the oxygen saturation at 10th minute after the heel puncture | |
Secondary | Change in respond of pain from 3rd minute before the heel puncture to 10th minute after the heel puncture | Pain response assessed using the Neonatal Infants Pain Scale (NIPS), The evaluation indicators include 6 behavior indicators: facial expression, crying, breathing pattern, arms, legs and awakening status, except that the crying score is divided into three points (0, 1, 2 points), and the rest are two points (0 , 1 point), the total score is 0-7 points, the higher the score, the more serious the pain. | Measure the NIPS at 3rd minute before the heel puncture | |
Secondary | Change in respond of pain from 3rd minute before the heel puncture to 10th minute after the heel puncture | Pain response assessed using the Neonatal Infants Pain Scale (NIPS), The evaluation indicators include 6 behavior indicators: facial expression, crying, breathing pattern, arms, legs and awakening status, except that the crying score is divided into three points (0, 1, 2 points), and the rest are two points (0 , 1 point), the total score is 0-7 points, the higher the score, the more serious the pain. | Measure the NIPS during the heel puncture | |
Secondary | Change in respond of pain from 3rd minute before the heel puncture to 10th minute after the heel puncture | Pain response assessed using the Neonatal Infants Pain Scale (NIPS), The evaluation indicators include 6 behavior indicators: facial expression, crying, breathing pattern, arms, legs and awakening status, except that the crying score is divided into three points (0, 1, 2 points), and the rest are two points (0 , 1 point), the total score is 0-7 points, the higher the score, the more serious the pain. | Measure the NIPS at 1st minute after the heel puncture | |
Secondary | Change in respond of pain from 3rd minute before the heel puncture to 10th minute after the heel puncture | Pain response assessed using the Neonatal Infants Pain Scale (NIPS), The evaluation indicators include 6 behavior indicators: facial expression, crying, breathing pattern, arms, legs and awakening status, except that the crying score is divided into three points (0, 1, 2 points), and the rest are two points (0 , 1 point), the total score is 0-7 points, the higher the score, the more serious the pain. | Measure the NIPS at 5th minute after the heel puncture | |
Secondary | Change in respond of pain from 3rd minute before the heel puncture to 10th minute after the heel puncture | Pain response assessed using the Neonatal Infants Pain Scale (NIPS), The evaluation indicators include 6 behavior indicators: facial expression, crying, breathing pattern, arms, legs and awakening status, except that the crying score is divided into three points (0, 1, 2 points), and the rest are two points (0 , 1 point), the total score is 0-7 points, the higher the score, the more serious the pain. | Measure the NIPS at 10th minute after the heel puncture |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05559255 -
Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI
|
N/A | |
Terminated |
NCT04356352 -
Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain
|
Phase 2/Phase 3 | |
Completed |
NCT04748367 -
Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care
|
N/A | |
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04466111 -
Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
|
||
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05868122 -
A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy
|
Phase 3 | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Completed |
NCT03273114 -
Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain
|
N/A | |
Enrolling by invitation |
NCT06087432 -
Is PNF Application Effective on Temporomandibular Dysfunction
|
N/A | |
Completed |
NCT05508594 -
Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001
|
Phase 2/Phase 3 | |
Recruiting |
NCT03646955 -
Partial Breast Versus no Irradiation for Women With Early Breast Cancer
|
N/A | |
Active, not recruiting |
NCT03472300 -
Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
|
||
Completed |
NCT03678168 -
A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries
|
N/A | |
Completed |
NCT03286543 -
Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System
|
N/A | |
Completed |
NCT03931772 -
Online Automated Self-Hypnosis Program
|
N/A | |
Completed |
NCT02913027 -
Can We Improve the Comfort of Pelvic Exams?
|
N/A | |
Terminated |
NCT02181387 -
Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor?
|
Phase 4 | |
Recruiting |
NCT06032559 -
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
|
Phase 3 | |
Active, not recruiting |
NCT03613155 -
Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care
|